Multimorbidity Trends in United States Adults, 1988–2014

References

1. 1.↵
   1. Jindai K,
   2. Nielson CM,
   3. Vorderstrasse BA,
   4. Quinones AR

   . Multimorbidity and functional limitations among adults 65 or older, NHANES 2005–2012. Prev Chronic Dis 2016;13:E151.

   OpenUrl
2. 2.↵
   1. Lebwohl M

   . Does Treatment of psoriasis reduce cardiovascular comorbidities? J Invest Dermatol 2017;137:1612–3.

   OpenUrl
3. 3.↵
   1. Mazarati AM,
   2. Lewis ML,
   3. Pittman QJ

   . Neurobehavioral comorbidities of epilepsy: role of inflammation. Epilepsia 2017;58:48–56.

   OpenUrl
4. 4.↵
   1. Lehrke M,
   2. Marx N

   . Diabetes mellitus and heart failure. Am J Cardiol 2017;120:S37–S47.

   OpenUrl
5. 5.↵
   1. Yin HL,
   2. Yin SQ,
   3. Lin QY,
   4. Xu Y,
   5. Xu HW,
   6. Liu T

   . Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine (Baltimore) 2017;96:e6836.

   OpenUrl
6. 6.↵
   1. Dong Q,
   2. Liu H,
   3. Yang D,
   4. Zhang Y

   . Diabetes mellitus and arthritis: is it a risk factor or comorbidity?: a systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e6627.

   OpenUrl
7. 7.↵
   1. Radner H

   . Multimorbidity in rheumatic conditions. Wien Klin Wochenschr 2016;128:786–790.

   OpenUrl
8. 8.↵
   1. Pefoyo AJ,
   2. Bronskill SE,
   3. Gruneir A,
   4. et al

   . The increasing burden and complexity of multimorbidity. BMC Public Health 2015;15:415.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Rosbach M,
   2. Andersen JS

   . Patient-experienced burden of treatment in patients with multi-morbidity- a systematic review of qualitative data. PLoS One 2017;12:e0179916.

   OpenUrl
10. 10.↵
    1. Nunes BP,
    2. Flores TR,
    3. Mielke GI,
    4. Thume E,
    5. Facchini LA

    . Multimorbidity and mortality in older adults: a systemic review and meta-analysis. Arch Gerontol Geriatr 2016;67:130–8.

    OpenUrlCrossRef
11. 11.↵
    1. Landi F,
    2. Liperoti R,
    3. Russo A,
    4. et al

    . Disability, more than multimorbidity, was predictive of mortality among older persons aged 80 years and older. J Clin Epidemiol 2010;63:752–9.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Menotti A,
    2. Mulder I,
    3. Nissinen A,
    4. Giampaoli S,
    5. Feskens E,
    6. Kromhout D

    . Prevalence of morbidity and mulitmorbidity in elderly male populations and their impact on 10-year all-cause mortality: the FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol 2001;54:680–6.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Chwastiak LA,
    2. Rosencheck RA,
    3. Desai R,
    4. Kazis LE

    . Association of psychiatric illness and all-cause mortality in the national department of veterans affairs health care system. Psychosom Med. 2010;72:817–22.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Censin JC,
    2. Nowak C,
    3. Cooper N,
    4. Bergsten P,
    5. Todd JA,
    6. Fall T

    . Childhood adiposity and risk of type 1 diabetes: a Mendelian randomization study. PLoS Med 2017;14:e1002362.

    OpenUrlPubMed
15. 15.↵
    1. Reho JJ,
    2. Rahmouni K

    . Oxidative and inflammatory signals in obesity-associated vascular abnormalities. Clin Sci (Lond) 2017;131:1689–700.

    OpenUrl
16. 16.↵
    1. King DE,
    2. Mainous AG 3rd.,
    3. Matheson EM,
    4. Everett CJ

    . Impact of healthy lifestyle on mortality in people with normal blood pressure, LDL cholesterol, and C-reactive protein. Eur J Prev Cardiol 2013;20:73–9.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Engin A

    . The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol 2017;960:1–17.

    OpenUrl
18. 18.↵
    1. Tune JD,
    2. Goodwill AG,
    3. Sassoon DJ,
    4. Mather KJ

    . Cardiovascular consequences of metabolic syndrome. Transl Res 2017;183:57–70.

    OpenUrl
19. 19.↵
    1. Lauby-Secretan B,
    2. Scoccianti C,
    3. Loomis D,
    4. Grosse Y,
    5. Bianchini F,
    6. Straif K

    . Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med 2016;375:794–8.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Kivimaki M,
    2. Kuosma E,
    3. Ferrie JE,
    4. et al

    . Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health 2017;2:e277–e85.

    OpenUrlPubMed
21. 21.↵
    National Center for Health Statistics. NHANES survey methods and analytic guidelines. Available from: https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx. Accessed May 2018.
22. 22.↵
    National Center for Health Statistics. NHANES analytic and reporting guidelines: the Third National Health and Nutrition Examination Survey, NHANES III (1988–1994). Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf. Published October 1996. Accessed May 2018.
23. 23.↵
    American Diabetes Association. Standards of medical care in diabetes-2018 abridged for primary care providers. Clin Diabetes 2018;36:14–37.

    OpenUrlFREE Full Text
24. 24.↵
    1. James PA,
    2. Oparil S,
    3. Carter BL,
    4. et al

    . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–20.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Cho YK,
    2. Jung CH,
    3. Kang YM,
    4. et al

    . 2013 ACC/AHA cholesterol guideline versus 2004 NCEP ATP III guideline in the prediction of coronary artery calcification progression in a Korean population. J Am Heart Assoc 2016;5:e003410.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Selvin E,
    2. Manzi J,
    3. Stevens LA,
    4. et al

    . Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988–1994, 1999–2004. Am J Kidney Dis 2007;50:918–26.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Levey AS,
    2. Stevens LA,
    3. Schmid CH,
    4. et al

    . A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    National Center for Health Statistics. Continuous NHANES web tutorial: specifying weighting parameters. Available from: https://www.cdc.gov/nchs/tutorials/nhanes/SurveyDesign/Weighting/intro.htm. Updated May 2013. Accessed March 2018.
29. 29.↵
    National Center for Health Statistics. Continuous NHANES web tutorial: age standardization and population counts. Available from: https://www.cdc.gov/nchs/tutorials/nhanes/NHANESAnalyses/AgeStandardization/age_standardization_intro.htm. Updated May 2014. Accessed May 2018.
30. 30.↵
    1. Ward BW,
    2. Schiller JS,
    3. Goodman RA

    . Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis 2014;11:E62.

    OpenUrlPubMed
31. 31.↵
    Centers for Disease Control and Prevention. Comorbidities. Available from: https://www.cdc.gov/arthritis/data_statistics/comorbidities.htm. Updated February 2018. Accessed May 2018.
32. 32.↵
    1. DuGoff EH,
    2. Canudas-Romo V,
    3. Buttorff C,
    4. Leff B,
    5. Anderson GF

    . Multiple chronic conditions and life expectancy: a life table analysis. Med Care 2014;52:688–94.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.↵
    1. Van Oostrom SH,
    2. Gijsen R,
    3. Stirbu I,
    4. et al

    . Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys. PLoS One 2016;11:e0160264.

    OpenUrl
34. 34.↵
    1. Pefoyo AJ,
    2. Bronskill SE,
    3. Gruneir A,
    4. et al

    . The increasing burden and complexity of multimorbidity. BMC Public Health 2015;15:415.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Rocca WA,
    2. Boyd CM,
    3. Grossardt BR,
    4. et al

    . Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity. Mayo Clin Proc 2014;89:1336–49.

    OpenUrlCrossRefPubMedWeb of Science
36. 36.↵
    1. Prince MJ,
    2. Wu F,
    3. Guo Y,
    4. et al

    . The burden of disease in older people and implications for health policy and practice. Lancet 2015;385:549–62.

    OpenUrlCrossRefPubMed
37. 37.↵
    1. Krishnaswami A,
    2. Maurer MS,
    3. Alexander KP

    . Contextualizing myocardial infarction: comorbidities and priorities in older adults. Am J Med 2017;130:1144–7.

    OpenUrl
38. 38.↵
    1. Dieter BP,
    2. Tuttle KR

    . Dietary strategies for cardiovascular health. Trends Cardiovasc Med 2017;27:295–313.

    OpenUrl
39. 39.↵
    1. Shook RP,
    2. Hand GA,
    3. Drenowatz C,
    4. et al

    . Low levels of physical activity are associated with dysregulation of energy intake and fat mass gain over 1 year. Am J Clin Nutr 2015;102:1332–8.

    OpenUrlAbstract/FREE Full Text
40. 40.↵
    1. Ali M,
    2. Li Y,
    3. O'Neal WT,
    4. Soliman EZ

    . Tobacco exposure as determined by serum cotinine and subclinical myocardial injury in individuals free from cardiovascular disease. Am J Cardiol 2017;120:1114–7.

    OpenUrl
41. 41.↵
    1. Amrock SM,
    2. Abraham CZ,
    3. Jung E,
    4. Morris PB,
    5. Shapiro MD

    . Risk factors for mortality among individuals with peripheral arterial disease. Am J Cardiol 2017;120:862–7.

    OpenUrl
42. 42.↵
    1. Bruce MA,
    2. Martins D,
    3. Duru K,
    4. et al

    . Church attendance, allostatic load and mortality in middle aged adults. PLoS One 2017;12:e0177618.

    OpenUrl
43. 43.↵
    1. King DE,
    2. Matheson E,
    3. Chirina S,
    4. Shankar A,
    5. Broman-Fulks J

    . The status of baby boomers' health in the United States; the healthiest generation? JAMA Intern Med 2013;173:385–6.

    OpenUrl
44. 44.↵
    1. Fleisch Marcus A,
    2. Illescas AH,
    3. Hohl BC,
    4. Llanos AA

    . Relationships between social isolation, neighborhood poverty, and cancer mortality in a population-based study of US adults. PLoS One 2017;12:e0173370.

    OpenUrl
45. 45.↵
    1. Wang HH,
    2. Wang JJ,
    3. Lawson KD,
    4. et al

    . Relationships of multimorbidity and income with hospital admissions in 3 health care systems. Ann Fam Med 2015;13:164–7.

    OpenUrlAbstract/FREE Full Text
46. 46.↵
    1. Chung RY,
    2. Mercer SW,
    3. Yip BH,
    4. et al

    . The association between types of regular primary care and hospitalization among people with and without multimorbidity: a household survey on 25,780 Chinese. Sci Rep 2016;6:29758.

    OpenUrl
47. 47.↵
    1. Pathirana TI,
    2. Jackson CA

    . Socioeconomic status and multimorbidity: a systematic review and meta-analysis. Aust N Z J Public Health 2018;42:186–194.

    OpenUrl
48. 48.↵
    1. Hilderink HB,
    2. Plasmans MH,
    3. Snijders BE,
    4. Boshuizen HC,
    5. Poos MJ,
    6. van Gool CH

    . Accounting for multimorbidity can affect the estimation of the burden of disease: a comparison of approaches. Arch Public Health 2016;74:37.

    OpenUrl
49. 49.↵
    1. Florence CS,
    2. Zhou C,
    3. Luo F,
    4. Xu L

    . The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care 2016;54:901–6.

    OpenUrl